Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade.
about
Renin-angiotensin system blockade: Its contribution and controversyAldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its α-kinase domainDisparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused ratsAldosterone and glomerular filtration--observations in the general populationEffects of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitroEpidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndromeAldosterone and progression of kidney disease.Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.Adrenalectomy prevents renal ischemia-reperfusion injury.Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats.Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.MiR-34c-5p and CaMKII are involved in aldosterone-induced fibrosis in kidney collecting duct cells.Endothelial mineralocorticoid receptor ablation does not alter blood pressure, kidney function or renal vessel contractility.Aldosterone effects on glomerular structure and function.Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study
P2860
Q26827221-A3CA85C6-BC68-45BF-BFF4-4D67EEB4165BQ34949485-4AC3CC37-223A-402C-A19D-EA4F7D340501Q35025420-13251B43-7E05-4969-8593-146E783D4CA4Q35115799-30BA0094-EC24-48B7-BE50-50192FFF0463Q36931242-5DE86E61-80DB-41CC-9E61-EB2037754E0DQ37195386-904FAD5F-A2BE-450A-B348-B830F5835527Q37378291-0050012E-49C2-4A06-8258-30D4F4379977Q39460266-4E78C1BF-A1F5-466F-BE2E-FB2015F3D618Q39853500-11312405-E6DD-415B-85FC-2BC93CAD5CDBQ43298131-1A598B75-EBEF-4181-9114-BC8F8D2776A9Q46108426-25E1FEF2-4737-4415-9858-B58794634A94Q46840795-85E55E96-8BC6-4D90-80F9-7E004DEA662EQ47603517-D8B67479-722E-40B3-BDC3-65C5AEB8E85EQ52731232-32C59B3A-A399-487A-8C5F-B161B1A185AAQ52923765-0829B83F-0515-4AF8-B98B-A6777590A503Q53670434-567D477E-DCFA-46E9-9943-833854347506Q58713912-EE495459-4FE8-4966-9E3F-C8F06D08D60D
P2860
Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms of disease: The rol ...... ical benefits of its blockade.
@ast
Mechanisms of disease: The rol ...... ical benefits of its blockade.
@en
type
label
Mechanisms of disease: The rol ...... ical benefits of its blockade.
@ast
Mechanisms of disease: The rol ...... ical benefits of its blockade.
@en
prefLabel
Mechanisms of disease: The rol ...... ical benefits of its blockade.
@ast
Mechanisms of disease: The rol ...... ical benefits of its blockade.
@en
P2093
P2860
P356
P1476
Mechanisms of disease: The rol ...... ical benefits of its blockade.
@en
P2093
Daniele Cusi
Lucia Del Vecchio
Mirella Procaccio
Sara Viganò
P2860
P356
10.1038/NCPNEPH0362
P577
2007-01-01T00:00:00Z